Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
Ravenscroft, Paula
Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia. [electronic resource] - Experimental neurology Jan 2004 - 36-46 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0014-4886
10.1016/j.expneurol.2003.09.001 doi
Animals
Antiparkinson Agents--adverse effects
Behavior, Animal--drug effects
Corpus Striatum--drug effects
Disease Models, Animal
Dopamine Agonists--therapeutic use
Dyskinesia, Drug-Induced--physiopathology
Enkephalins--genetics
Gene Expression--drug effects
In Situ Hybridization
Indoles--therapeutic use
Levodopa--adverse effects
Male
Motor Activity--drug effects
Opioid Peptides--genetics
Oxidopamine
Parkinsonian Disorders--chemically induced
Protein Precursors--genetics
RNA, Messenger--metabolism
Rats
Rats, Sprague-Dawley
Synaptic Transmission--drug effects
Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia. [electronic resource] - Experimental neurology Jan 2004 - 36-46 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0014-4886
10.1016/j.expneurol.2003.09.001 doi
Animals
Antiparkinson Agents--adverse effects
Behavior, Animal--drug effects
Corpus Striatum--drug effects
Disease Models, Animal
Dopamine Agonists--therapeutic use
Dyskinesia, Drug-Induced--physiopathology
Enkephalins--genetics
Gene Expression--drug effects
In Situ Hybridization
Indoles--therapeutic use
Levodopa--adverse effects
Male
Motor Activity--drug effects
Opioid Peptides--genetics
Oxidopamine
Parkinsonian Disorders--chemically induced
Protein Precursors--genetics
RNA, Messenger--metabolism
Rats
Rats, Sprague-Dawley
Synaptic Transmission--drug effects